|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,038.50 JPY | -1.04% |
|
-7.15% | +33.30% |
| Oct. 10 | Rorze's Attributable Profit Drops 31% in Fiscal H1 | MT |
| Aug. 01 | Tranche Update on Rorze Corporation's Equity Buyback Plan announced on April 11, 2025. | CI |
| Fiscal Period: February | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 10.19 | 13.37 | 15.38 | 10.68 | 11.64 | |||||
Return on Total Capital | 11.92 | 16.14 | 18.48 | 12.49 | 13.6 | |||||
Return On Equity % | 21.91 | 32.59 | 36.31 | 23.04 | 20.27 | |||||
Return on Common Equity | 23 | 33.59 | 37.6 | 24.38 | 22.49 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 28.97 | 33.79 | 36.82 | 37.81 | 39.88 | |||||
SG&A Margin | 8.88 | 7.89 | 7.1 | 10 | 12.27 | |||||
EBITDA Margin % | 20.87 | 25.87 | 30.04 | 28.89 | 29.39 | |||||
EBITA Margin % | 18.33 | 23.6 | 27.95 | 26.16 | 27.1 | |||||
EBIT Margin % | 18.33 | 23.6 | 27.95 | 25.89 | 25.74 | |||||
Income From Continuing Operations Margin % | 13.63 | 20.63 | 24.01 | 21.54 | 18.6 | |||||
Net Income Margin % | 12.74 | 19.14 | 22.62 | 20.99 | 19 | |||||
Net Avail. For Common Margin % | 12.74 | 19.14 | 22.62 | 20.99 | 19 | |||||
Normalized Net Income Margin | 9.31 | 15.32 | 18.87 | 17.68 | 18.62 | |||||
Levered Free Cash Flow Margin | 8.91 | -1.88 | -14.22 | 8.61 | 22.16 | |||||
Unlevered Free Cash Flow Margin | 8.96 | -1.85 | -14.19 | 8.66 | 22.21 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.89 | 0.91 | 0.88 | 0.66 | 0.72 | |||||
Fixed Assets Turnover | 3.07 | 3.93 | 4.78 | 4.17 | 5.29 | |||||
Receivables Turnover (Average Receivables) | 4.5 | 4.44 | 4.15 | 3.51 | 4.36 | |||||
Inventory Turnover (Average Inventory) | 3.17 | 2.65 | 1.83 | 1.21 | 1.46 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.12 | 2.33 | 3.03 | 3.3 | 3.58 | |||||
Quick Ratio | 1.49 | 1.49 | 1.66 | 1.77 | 2.3 | |||||
Operating Cash Flow to Current Liabilities | 0.43 | 0.11 | -0.06 | 0.43 | 0.9 | |||||
Days Sales Outstanding (Average Receivables) | 81.12 | 82.12 | 87.99 | 104.32 | 83.62 | |||||
Days Outstanding Inventory (Average Inventory) | 115.08 | 137.97 | 199.45 | 303.32 | 249.98 | |||||
Average Days Payable Outstanding | 29.11 | 31.04 | 32.34 | 36.74 | 36.34 | |||||
Cash Conversion Cycle (Average Days) | 167.09 | 189.05 | 255.1 | 370.9 | 297.26 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 48.46 | 41.59 | 43.89 | 34.67 | 24.56 | |||||
Total Debt / Total Capital | 32.64 | 29.37 | 30.5 | 25.74 | 19.72 | |||||
LT Debt/Equity | 15.31 | 17.84 | 23.92 | 18.26 | 12.94 | |||||
Long-Term Debt / Total Capital | 10.31 | 12.6 | 16.62 | 13.56 | 10.39 | |||||
Total Liabilities / Total Assets | 41.87 | 43.12 | 40.87 | 36.24 | 31.44 | |||||
EBIT / Interest Expense | 211.68 | 416.05 | 539.14 | 344.84 | 320.25 | |||||
EBITDA / Interest Expense | 241 | 456.08 | 579.55 | 384.9 | 365.62 | |||||
(EBITDA - Capex) / Interest Expense | 188.27 | 402.39 | 487.51 | 367.5 | 346.16 | |||||
Total Debt / EBITDA | 1.58 | 1.21 | 1.16 | 1.28 | 0.86 | |||||
Net Debt / EBITDA | -0.01 | -0.16 | 0.16 | -0.13 | -0.86 | |||||
Total Debt / (EBITDA - Capex) | 2.02 | 1.37 | 1.37 | 1.34 | 0.91 | |||||
Net Debt / (EBITDA - Capex) | -0.01 | -0.18 | 0.19 | -0.13 | -0.91 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 36.92 | 31.89 | 41.06 | -1.34 | 33.42 | |||||
Gross Profit, 1 Yr. Growth % | 10.82 | 53.8 | 53.74 | 1.3 | 40.73 | |||||
EBITDA, 1 Yr. Growth % | 21.83 | 63.44 | 63.86 | -5.12 | 35.7 | |||||
EBITA, 1 Yr. Growth % | 20.27 | 69.74 | 67.1 | -7.65 | 38.2 | |||||
EBIT, 1 Yr. Growth % | 20.27 | 69.74 | 67.1 | -8.63 | 32.67 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 25.56 | 99.7 | 64.2 | -11.5 | 15.18 | |||||
Net Income, 1 Yr. Growth % | 18.28 | 98.21 | 66.75 | -8.46 | 20.73 | |||||
Normalized Net Income, 1 Yr. Growth % | 0.97 | 117.15 | 73.7 | -7.54 | 40.53 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 18.21 | 98.17 | 66.74 | -10.2 | 20.81 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.08 | 67.11 | 41.61 | -0.99 | 15.54 | |||||
Inventory, 1 Yr. Growth % | -4.49 | 101.75 | 91.01 | 24.4 | -7.75 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.5 | 4.95 | 26.43 | 2.35 | 8.09 | |||||
Total Assets, 1 Yr. Growth % | 8.68 | 48.31 | 43.26 | 23.45 | 20.24 | |||||
Tangible Book Value, 1 Yr. Growth % | 22.58 | 47.58 | 50.97 | 28.69 | 20.92 | |||||
Common Equity, 1 Yr. Growth % | 21.97 | 46.98 | 50.34 | 35.12 | 27.74 | |||||
Cash From Operations, 1 Yr. Growth % | 22.5 | -63.03 | -163.66 | -909.58 | 136.69 | |||||
Capital Expenditures, 1 Yr. Growth % | -59.36 | -12.07 | 121.08 | -72.99 | 59.77 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 351.15 | -127.87 | 965.43 | -159.77 | 243.22 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 344.75 | -127.18 | 983.4 | -160.23 | 242.13 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 107.69 | 0 | 25.93 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 27.26 | 34.38 | 36.4 | 17.97 | 14.73 | |||||
Gross Profit, 2 Yr. CAGR % | 18.12 | 30.55 | 53.77 | 24.8 | 19.4 | |||||
EBITDA, 2 Yr. CAGR % | 28.5 | 41.11 | 63.65 | 24.68 | 13.47 | |||||
EBITA, 2 Yr. CAGR % | 26.58 | 42.88 | 68.42 | 24.22 | 12.97 | |||||
EBIT, 2 Yr. CAGR % | 26.58 | 42.88 | 68.42 | 23.56 | 10.1 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 26.17 | 58.35 | 81.08 | 20.55 | 0.97 | |||||
Net Income, 2 Yr. CAGR % | 21.3 | 53.12 | 81.8 | 23.55 | 5.13 | |||||
Normalized Net Income, 2 Yr. CAGR % | 11.19 | 48.07 | 94.21 | 26.73 | 13.99 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 21.21 | 53.05 | 81.78 | 22.36 | 4.16 | |||||
Accounts Receivable, 2 Yr. CAGR % | 20.25 | 29.22 | 53.83 | 18.41 | 6.96 | |||||
Inventory, 2 Yr. CAGR % | -11.11 | 38.81 | 96.31 | 54.15 | 7.13 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 19.65 | 3.21 | 15.19 | 13.76 | 5.18 | |||||
Total Assets, 2 Yr. CAGR % | 11.96 | 26.96 | 45.76 | 32.98 | 21.83 | |||||
Tangible Book Value, 2 Yr. CAGR % | 22.12 | 34.5 | 49.27 | 39.39 | 24.74 | |||||
Common Equity, 2 Yr. CAGR % | 22.49 | 33.89 | 48.65 | 42.53 | 31.38 | |||||
Cash From Operations, 2 Yr. CAGR % | 133.66 | -32.7 | -51.48 | 127.02 | 337.74 | |||||
Capital Expenditures, 2 Yr. CAGR % | -27.9 | -40.22 | 39.43 | -22.73 | -34.31 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -15.8 | 12.13 | 72.31 | 152.35 | 43.23 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -15.44 | 9.94 | 71.59 | 155.45 | 43.55 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 47.2 | - | 44.12 | 12.22 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.93 | 28.79 | 36.57 | 22.44 | 22.91 | |||||
Gross Profit, 3 Yr. CAGR % | 16.79 | 28.98 | 37.86 | 33.8 | 29.9 | |||||
EBITDA, 3 Yr. CAGR % | 30.76 | 39.23 | 48.32 | 36.46 | 28.25 | |||||
EBITA, 3 Yr. CAGR % | 29.67 | 39.59 | 50.54 | 37.85 | 28.72 | |||||
EBIT, 3 Yr. CAGR % | 30.03 | 39.59 | 50.54 | 37.36 | 26.53 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 33.37 | 47.04 | 60.27 | 42.64 | 18.73 | |||||
Net Income, 3 Yr. CAGR % | 33.11 | 42.87 | 57.53 | 44.63 | 22.6 | |||||
Normalized Net Income, 3 Yr. CAGR % | 25.91 | 38.98 | 56.17 | 51.65 | 31.17 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 33.05 | 42.79 | 57.49 | 43.7 | 21.84 | |||||
Accounts Receivable, 3 Yr. CAGR % | 13.49 | 34.2 | 33.22 | 32.82 | 17.45 | |||||
Inventory, 3 Yr. CAGR % | 14.42 | 16.81 | 54.4 | 68.61 | 29.9 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 28.19 | 14.53 | 10.43 | 10.74 | 11.84 | |||||
Total Assets, 3 Yr. CAGR % | 20.64 | 22.96 | 32.17 | 37.91 | 28.59 | |||||
Tangible Book Value, 3 Yr. CAGR % | 21.88 | 30.08 | 39.78 | 42.07 | 32.94 | |||||
Common Equity, 3 Yr. CAGR % | 22.01 | 30.16 | 39.16 | 44 | 37.42 | |||||
Cash From Operations, 3 Yr. CAGR % | 571 | 26.38 | -33.94 | 23.98 | 130.2 | |||||
Capital Expenditures, 3 Yr. CAGR % | 7.72 | -22.97 | -7.56 | -19.33 | -1.56 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 20.72 | -41.76 | 137.49 | 21.07 | 179.59 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 21.26 | -42.08 | 135.71 | 21.04 | 181.58 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 37.51 | 65.1 | - | 37.78 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 20.57 | 22.05 | 12.59 | 24.35 | 27.38 | |||||
Gross Profit, 5 Yr. CAGR % | 19.32 | 23.12 | 30.38 | 27.29 | 30.16 | |||||
EBITDA, 5 Yr. CAGR % | 26.11 | 28.42 | 43.04 | 33.22 | 33.25 | |||||
EBITA, 5 Yr. CAGR % | 25.96 | 28.16 | 43.96 | 33.22 | 34.21 | |||||
EBIT, 5 Yr. CAGR % | 25.96 | 28.16 | 44.21 | 32.94 | 32.83 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 25.28 | 33.65 | 50.72 | 35.81 | 33.23 | |||||
Net Income, 5 Yr. CAGR % | 24.52 | 33.23 | 50.79 | 34.81 | 34 | |||||
Normalized Net Income, 5 Yr. CAGR % | 20.66 | 30.78 | 49.75 | 33.95 | 37.69 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 24.48 | 33.18 | 50.74 | 34.24 | 33.48 | |||||
Accounts Receivable, 5 Yr. CAGR % | 14.02 | 20.87 | 28.17 | 27.64 | 22.02 | |||||
Inventory, 5 Yr. CAGR % | 19.7 | 35.92 | 42 | 30.52 | 33.4 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 22.65 | 21.71 | 22.82 | 14.22 | 8.3 | |||||
Total Assets, 5 Yr. CAGR % | 21.49 | 26.76 | 30.12 | 26.87 | 27.94 | |||||
Tangible Book Value, 5 Yr. CAGR % | 21.83 | 26.31 | 32.17 | 33.72 | 33.56 | |||||
Common Equity, 5 Yr. CAGR % | 21.75 | 26.23 | 32.04 | 34.97 | 36 | |||||
Cash From Operations, 5 Yr. CAGR % | 48.04 | -3.81 | 134.63 | 59.75 | 40.76 | |||||
Capital Expenditures, 5 Yr. CAGR % | 45.08 | 13.21 | 19.43 | -22.87 | -19.37 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 57.32 | -10.76 | 39.18 | 4.7 | 94 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 56.36 | -11.19 | 39.32 | 4.87 | 93.3 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 26.58 | 46.51 | 40.11 | 41.47 |
- Stock Market
- Equities
- 6323 Stock
- Financials Rorze Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















